Belimumab Not Yet Recruiting Phase 4 Trials for Systemic Lupus Erythematosus Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04893161A Model About the Response of Belimumab in SLE